Thintech Materials, a subsidiary of China Steel Corporation, is ramping up its semiconductor operations with expected significant growth by 2025, driven by target and evaporation materials production. The company is also diversifying into biomedical technology, with Taiwan’s first accelerator-based boron neutron capture therapy equipment scheduled for delivery this year.